Patient-to-Patient Transmission of Klebsiella pneumoniae Carbapenemase Variants with Reduced Ceftazidime-Avibactam Susceptibility
Authors:
- 1 October 2019
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 63 (10)
Abstract
We report patient-to-patient transmission of Enterobacter hormaechei isolates with reduced susceptibility to ceftazidime-avibactam due to production of KPC-40, a variant of KPC-3 with a two-amino-acid insertion in the Ω-loop region (L167_E168dup). The index patient had received a prolonged course of ceftazidime-avibactam therapy, whereas the second patient had not received the agent and still became colonized with the KPC-40-producing strain.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (K08AI114883, R03AI144636)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI104895, R21AI135522)
- HHS | NIH | National Eye Institute (R00EY028222)
This publication has 13 references indexed in Scilit:
- Use of a cohorting-unit and systematic surveillance cultures to control aKlebsiella pneumoniaecarbapenemase (KPC)–producing Enterobacteriaceae outbreakInfection Control & Hospital Epidemiology, 2019
- Klebsiella pneumoniae Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein EngineeringmBio, 2017
- Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant EnterobacteriaceaeClinical Infectious Diseases, 2017
- Mutations inblaKPC-3That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum β-LactamasesAntimicrobial Agents and Chemotherapy, 2017
- Genomic Characterization of Two KPC-Producing Klebsiella Isolates Collected in 1997 in New York CityAntimicrobial Agents and Chemotherapy, 2017
- Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae InfectionsAntimicrobial Agents and Chemotherapy, 2017
- Microbiological features of KPC-producing Enterobacter isolates identified in a U.S. hospital systemDiagnostic Microbiology and Infectious Disease, 2014
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemasesThe Lancet Infectious Diseases, 2013
- Substrate Selectivity and a Novel Role in Inhibitor Discrimination by Residue 237 in the KPC-2 β-LactamaseAntimicrobial Agents and Chemotherapy, 2010
- Simple Disk-Based Method for Detection of Klebsiella pneumoniae Carbapenemase-Type β-Lactamase by Use of a Boronic Acid CompoundJournal of Clinical Microbiology, 2008